rs200336777

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4BP6_ModerateBS1BS2

The ENST00000361789.2(MT-CYB):​c.1066G>A​(p.Val356Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 4/4 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V356A) has been classified as Benign.

Frequency

Mitomap GenBank:
𝑓 0.0084 ( AC: 513 )

Consequence

MT-CYB
ENST00000361789.2 missense

Scores

Apogee2
Benign
0.098

Clinical Significance

Benign criteria provided, single submitter P:1B:1
LHON

Conservation

PhyloP100: -0.327

Publications

8 publications found
Variant links:
Genes affected
MT-CYB (HGNC:7427): (mitochondrially encoded cytochrome b) Predicted to enable metal ion binding activity. Predicted to be involved in several processes, including electron transport coupled proton transport; response to cobalamin; and response to glucagon. Located in mitochondrion. Implicated in ovarian carcinoma and urinary bladder cancer. [provided by Alliance of Genome Resources, Apr 2022]
TRNT (HGNC:7499): (mitochondrially encoded tRNA threonine)
TRNP (HGNC:7494): (mitochondrially encoded tRNA proline)
TRNP Gene-Disease associations (from GenCC):
  • MERRF syndrome
    Inheritance: Mitochondrial Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • mitochondrial disease
    Inheritance: Mitochondrial Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Apogee2 supports a benign effect, 0.09807686 < 0.5 .
BP6
Variant M-15812-G-A is Benign according to our data. Variant chrM-15812-G-A is described in ClinVar as Benign. ClinVar VariationId is 9675.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
High frequency in mitomap database: 0.0084
BS2
High AC in GnomadMitoHomoplasmic at 656

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000361789.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MT-CYB
ENST00000361789.2
TSL:6
c.1066G>Ap.Val356Met
missense
Exon 1 of 1ENSP00000354554.2P00156
MT-TT
ENST00000387460.2
TSL:6
n.-76G>A
upstream_gene
N/A
MT-TP
ENST00000387461.2
TSL:6
n.*144C>T
downstream_gene
N/A

Frequencies

Mitomap GenBank
AF:
0.0084
AC:
513
Gnomad homoplasmic
AF:
0.012
AC:
656
AN:
56424
Gnomad heteroplasmic
AF:
0.000071
AC:
4
AN:
56424
Alfa
AF:
0.0152
Hom.:
203

Mitomap

Disease(s): LHON
Status: Reported-/-Secondary
Publication(s): 7770132

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Leber optic atrophy (1)
-
-
1
Leigh syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
Apogee2
Benign
0.098
Hmtvar
Benign
0.14
AlphaMissense
Benign
0.095
PhyloP100
-0.33
Mutation Taster
=75/25
polymorphism

Publications

Other links and lift over

dbSNP: rs200336777; hg19: chrM-15813; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.